Frazier Financial Advisors LLC Makes New $1.13 Million Investment in Bath & Body Works, Inc. $BBWI

Frazier Financial Advisors LLC acquired a new stake in Bath & Body Works, Inc. (NYSE:BBWI) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 48,728 shares of the company’s stock, valued at approximately $1,127,000. Bath & Body Works accounts for approximately 0.6% of Frazier Financial Advisors LLC’s holdings, making the stock its 18th largest holding.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Global Retirement Partners LLC acquired a new position in shares of Bath & Body Works in the fourth quarter valued at $31,000. Activest Wealth Management bought a new position in shares of Bath & Body Works during the fourth quarter worth approximately $32,000. Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares in the last quarter. Parallel Advisors LLC boosted its stake in shares of Bath & Body Works by 42.6% in the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after buying an additional 567 shares during the period. Finally, Danske Bank A S bought a new stake in shares of Bath & Body Works in the third quarter valued at approximately $39,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Trading Down 1.5%

NYSE BBWI opened at $19.73 on Thursday. The company has a market cap of $3.98 billion, a P/E ratio of 5.54, a PEG ratio of 1.98 and a beta of 1.38. The company has a fifty day simple moving average of $20.45 and a 200 day simple moving average of $20.12. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $32.32.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The firm had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the prior year, the company posted $0.49 earnings per share. The business’s revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Sell-side analysts predict that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be given a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 annualized dividend and a yield of 4.1%. Bath & Body Works’s payout ratio is currently 22.47%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on BBWI shares. Barclays decreased their target price on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a report on Thursday, May 28th. TD Cowen upped their target price on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, May 27th. Jefferies Financial Group upped their price target on shares of Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Finally, Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 9th. Four research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $22.57.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.